Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Overactive Bladder Modeling

Overactive Bladder (OAB) is characterized by symptoms such as increased urinary frequency, urgency, and nocturia. Common modeling strategies include denervation approaches (e.g., sympathetic or parasympathetic nerve removal), low-dose long-term cyclophosphamide stimulation, and urethral obstruction. These models are used to study neural regulation of the urinary system and drug responsiveness.

Cyclophosphamide
T0707L50-18-0
Cyclophosphamide is an alkylating agent type of anti-tumor drug, and its main target is DNA. Cyclophosphamide inhibits the proliferation of tumor cells by undergoing alkylation reactions with DNA, interfering with the replication and transcription processes of DNA.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Oxybutynin
T1049L5633-20-5
Oxybutynin (Ditropan) is a synthetic anticholinergic agent that is used for treatment of urinary incontinence and overactive bladder syndrome.
  • $35
In Stock
Size
QTY